About Scleroderma

Scleroderma affects over 300,000 people in North America. Because it is relatively uncommon and has a wide variety of symptoms, it’s difficult to diagnose; many patients suffer with scleroderma for years before getting a diagnosis. Yet early diagnosis is key to helping patients have a better quality of life.

Here are some facts you can share with others to raise awareness of scleroderma.

We gratefully acknowledge corporate support from Boehringer Ingelheim, GmbH. and Actelion Pharmaceuticals US, Inc.